Last 12 months
Inside the activity.
2 purchase rows · 112 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 26 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 56 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2022 Filed May 9, 2022 21:03 UTC |
Frank John EdwardChief Public Affairs Officer
|
GrantPerformance Shares · Derivative | 5,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013861 · form4.xml · derivative · entry 2 Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,142 Underlying: Common Stock · 5,142 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| May 05, 2022 Filed May 9, 2022 21:03 UTC |
Frank John EdwardChief Public Affairs Officer
|
GrantCommon Stock | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013861 · form4.xml · nonDerivative · entry 1 Frank John Edward · CIK 0001921247 · Chief Public Affairs Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,714 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of May 5, 2023, May 5, 2024, May 5, 2025, and May 5, 2026, subject to awardee's continuing status as a service provider on such dates. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:54 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 368 | $300.13 | $110,447.84 |
DisclosureSEC source: 0001127602-22-012861 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 7,427 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:33 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 100 | $355.38 | $35,538.00 |
DisclosureSEC source: 0001127602-22-011971 · form4.xml · nonDerivative · entry 7 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,342 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:33 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 1,553 | $352.82 | $547,929.46 |
DisclosureSEC source: 0001127602-22-011971 · form4.xml · nonDerivative · entry 6 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,442 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F5 · price: Weighted average sale price representing 1,553 shares sold ranging from $352.43 to $353.19 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:33 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 300 | $349.46 | $104,838.00 |
DisclosureSEC source: 0001127602-22-011971 · form4.xml · nonDerivative · entry 5 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,995 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F4 · price: Weighted average sale price representing 300 shares sold ranging from $349.22 to $349.87 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:33 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 100 | $346.25 | $34,625.00 |
DisclosureSEC source: 0001127602-22-011971 · form4.xml · nonDerivative · entry 4 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,295 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:33 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 121 | $344.78 | $41,718.38 |
DisclosureSEC source: 0001127602-22-011971 · form4.xml · nonDerivative · entry 3 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,395 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F3 · price: Weighted average sale price representing 121 shares sold ranging from $344.77 to $344.85 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:33 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 100 | $342.98 | $34,298.00 |
DisclosureSEC source: 0001127602-22-011971 · form4.xml · nonDerivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,516 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 12, 2022 Filed Apr 14, 2022 20:33 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
SaleCommon Stock | 200 | $341.13 | $68,226.00 |
DisclosureSEC source: 0001127602-22-011971 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,616 F1 · shares: The sale was made pursuant to a 10b5-1 plan. F2 · price: Weighted average sale price representing 200 shares sold ranging from $340.96 to $341.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 20:19 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
SaleCommon Stock | 1,988 | $360.01 | $715,699.88 |
DisclosureSEC source: 0001127602-22-011725 · form4.xml · nonDerivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,774 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:19 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
Tax withholdingCommon Stock | 131 | $363.84 | $47,663.04 |
DisclosureSEC source: 0001127602-22-011725 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,762 Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:22 UTC |
Pegels Kevin CarlChief of Global Operations
|
Tax withholdingCommon Stock | 125 | $363.84 | $45,480.00 |
DisclosureSEC source: 0001127602-22-011727 · form4.xml · nonDerivative · entry 1 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,914 Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:17 UTC |
Rollins CarissaSVP, Chief Information Officer
|
GrantPerformance Shares · Derivative | 4,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011724 · form4.xml · derivative · entry 2 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,123 Underlying: Common Stock · 4,123 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:17 UTC |
Rollins CarissaSVP, Chief Information Officer
|
GrantCommon Stock | 1,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011724 · form4.xml · nonDerivative · entry 1 Rollins Carissa · CIK 0001916557 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of April 5, 2023, April 5, 2024, April 5, 2025, and April 5, 2026, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 23:02 UTC |
Dadswell CharlesSVP & General Counsel
|
SaleCommon Stock | 368 | $342.83 | $126,161.44 |
DisclosureSEC source: 0001127602-22-010683 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 7,795 F1 · shares: The sale was made pursuant to a 10b5-1 plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:31 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
GrantPerformance Shares · Derivative | 6,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008114 · form4.xml · derivative · entry 2 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Underlying: Common Stock · 6,246 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:31 UTC |
GOSWAMI JOYDEEPSVP Corp Business Development
|
GrantCommon Stock | 2,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008114 · form4.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · SVP Corp Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,385 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:49 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
GrantPerformance Shares · Derivative | 12,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008124 · form4.xml · derivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,113 Underlying: Common Stock · 12,113 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:49 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 34,999 | $330.25 Strike: $330.25 | $11,558,419.75 |
DisclosureSEC source: 0001127602-22-008124 · form4.xml · derivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,999 Underlying: Common Stock · 34,999 shares Expires 2029-03-01 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option become exercisable on the date indicated above, subject to optionee's continuing to be a service provider on such date. An additional 25% of the shares subject to the option shall become exercisable each year thereafter, subject to optionee's continuing to be a service provider on such date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:47 UTC |
TORRES JOSEVP, Chief Accounting Officer
|
GrantPerformance Shares · Derivative | 1,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008123 · form4.xml · derivative · entry 2 TORRES JOSE · CIK 0001666638 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,454 Underlying: Common Stock · 1,454 shares Expires 2024-12-29 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:47 UTC |
TORRES JOSEVP, Chief Accounting Officer
|
GrantCommon Stock | 969 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008123 · form4.xml · nonDerivative · entry 1 TORRES JOSE · CIK 0001666638 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,817 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. F2 · balance_after: Balance includes 49 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:43 UTC |
SAMAD SAMSVP and CFO
|
GrantPerformance Shares · Derivative | 6,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008120 · form4.xml · derivative · entry 2 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Underlying: Common Stock · 6,246 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:43 UTC |
SAMAD SAMSVP and CFO
|
GrantCommon Stock | 2,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008120 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:40 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
GrantPerformance Shares · Derivative | 6,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008119 · form4.xml · derivative · entry 2 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Underlying: Common Stock · 6,246 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:40 UTC |
Reeves Kathryne GambrellSVP, Chief Marketing Officer
|
GrantCommon Stock | 2,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008119 · form4.xml · nonDerivative · entry 1 Reeves Kathryne Gambrell · CIK 0001824170 · SVP, Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,469 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:37 UTC |
Pegels Kevin CarlChief of Global Operations
|
GrantPerformance Shares · Derivative | 4,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008117 · form4.xml · derivative · entry 2 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,543 Underlying: Common Stock · 4,543 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:37 UTC |
Pegels Kevin CarlChief of Global Operations
|
GrantCommon Stock | 1,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008117 · form4.xml · nonDerivative · entry 1 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,039 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:34 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantPerformance Shares · Derivative | 6,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008115 · form4.xml · derivative · entry 2 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Underlying: Common Stock · 6,246 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:34 UTC |
Hoyt Aimee LSVP, Chief People Officer
|
GrantCommon Stock | 2,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008115 · form4.xml · nonDerivative · entry 1 Hoyt Aimee L · CIK 0001727683 · SVP, Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,816 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:28 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantPerformance Shares · Derivative | 9,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008112 · form4.xml · derivative · entry 2 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,085 Underlying: Common Stock · 9,085 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:28 UTC |
Febbo Phillip G.SVP Chief Medical Officer
|
GrantCommon Stock | 3,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008112 · form4.xml · nonDerivative · entry 1 Febbo Phillip G. · CIK 0001649245 · SVP Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:26 UTC |
deSouza Francis ADirector · President and CEO
|
GrantPerformance Shares · Derivative | 37,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008110 · form4.xml · derivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,851 Underlying: Common Stock · 37,851 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:26 UTC |
deSouza Francis ADirector · President and CEO
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 109,371 | $0.00 Strike: $330.25 | $0.00 |
DisclosureSEC source: 0001127602-22-008110 · form4.xml · derivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,371 Underlying: Common Stock · 109,371 shares Expires 2029-03-01 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option become exercisable on the date indicated above, subject to the optionee's continuing to be a service provider on such date. An additional 25% of the shares subject to the option shall become exercisable each year thereafter subject to optionee's continuing to be a service provider on such date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantPerformance Shares · Derivative | 12,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008105 · form4.xml · derivative · entry 2 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,113 Underlying: Common Stock · 12,113 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:21 UTC |
Aravanis AlexanderSVP, Chief Technology Officer
|
GrantNon-qualified Stock Option (Right to Buy) · Derivative | 34,999 | $330.25 Strike: $330.25 | $11,558,419.75 |
DisclosureSEC source: 0001127602-22-008105 · form4.xml · derivative · entry 1 Aravanis Alexander · CIK 0001812464 · SVP, Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,999 Underlying: Common Stock · 34,999 shares Expires 2029-03-01 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option become exercisable on the date indicated above, subject to optionee's continuing to be a service provider on such date. An additional 25% of the shares subject to the option shall become exercisable each year thereafter, subject to optionee's continuing to be a service provider on such date. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:23 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantPerformance Shares · Derivative | 6,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008107 · form4.xml · derivative · entry 2 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,246 Underlying: Common Stock · 6,246 shares Expires 2024-12-29 F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. F2 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:23 UTC |
Dadswell CharlesSVP & General Counsel
|
GrantCommon Stock | 2,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008107 · form4.xml · nonDerivative · entry 1 Dadswell Charles · CIK 0001575229 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By The Charles Dadswell Trust Disclosed balance after: 8,163 F1 · shares: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:43 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionPerformance Shares · Derivative | 19,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006632 · form4.xml · derivative · entry 3 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,383 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:43 UTC |
deSouza Francis ADirector · President and CEO
|
Tax withholdingCommon Stock | 9,144 | $319.86 | $2,924,799.84 |
DisclosureSEC source: 0001127602-22-006632 · form4.xml · nonDerivative · entry 2 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,443 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:43 UTC |
deSouza Francis ADirector · President and CEO
|
Exercise / conversionCommon Stock | 19,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006632 · form4.xml · nonDerivative · entry 1 deSouza Francis A · CIK 0001520943 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F2 · balance_after: Balance includes 54 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:42 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
Exercise / conversionPerformance Shares · Derivative | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006630 · form4.xml · derivative · entry 3 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,561 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:42 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 1,808 | $319.86 | $578,306.88 |
DisclosureSEC source: 0001127602-22-006630 · form4.xml · nonDerivative · entry 2 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,083 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:42 UTC |
TOUSI SUSAN HSVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006630 · form4.xml · nonDerivative · entry 1 TOUSI SUSAN H · CIK 0001791938 · SVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F2 · balance_after: Balance includes 56 shares acquired through Employee Stock Purchase Plan. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:39 UTC |
SAMAD SAMSVP and CFO
|
Exercise / conversionPerformance Shares · Derivative | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006629 · form4.xml · derivative · entry 3 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,561 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:39 UTC |
SAMAD SAMSVP and CFO
|
Tax withholdingCommon Stock | 1,808 | $319.86 | $578,306.88 |
DisclosureSEC source: 0001127602-22-006629 · form4.xml · nonDerivative · entry 2 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,215 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:39 UTC |
SAMAD SAMSVP and CFO
|
Exercise / conversionCommon Stock | 4,561 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006629 · form4.xml · nonDerivative · entry 1 SAMAD SAM · CIK 0001694295 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:38 UTC |
Pegels Kevin CarlChief of Global Operations
|
Exercise / conversionPerformance Shares · Derivative | 1,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006628 · form4.xml · derivative · entry 3 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,065 shares Expires 2022-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. F1 · derivative.exercise_date: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:38 UTC |
Pegels Kevin CarlChief of Global Operations
|
Tax withholdingCommon Stock | 386 | $319.86 | $123,465.96 |
DisclosureSEC source: 0001127602-22-006628 · form4.xml · nonDerivative · entry 2 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,524 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:38 UTC |
Pegels Kevin CarlChief of Global Operations
|
Exercise / conversionCommon Stock | 1,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006628 · form4.xml · nonDerivative · entry 1 Pegels Kevin Carl · CIK 0001892104 · Chief of Global Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.